Research funder · United States
Alzheimer's Association
A non-profit American health organization which focuses Alzheimer's disease
- Grants since 2016
- 1 779
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 7 372
- Funded works, all time
- 14.6k
Grants
2025 · research · AARF-D
DAILY ACTivities Signatures in the Dementia Continuum
Adrián Noriega De La Colina · Montreal Neurological Institute and Hospital
2025 · research · AARF-D
Uncover Spatial Molecular Signatures of Microglia Phenotypes in Alzheimer’s Disease
Yi Zhou · Regent University
2025 · research · VCID-UMD
Loss of pericytic laminin induces vascular dysfunction and AD pathogenesis
Yao Yao · University of South Florida
2025 · research · AARG
Lifecourse reproductive and social-environmental determinants of AD risk
Jacqueline Torres · Regent University
2025 · research · AARF-D
Deciphering Tau Aggregate Proteomes Associated with AD Resilience
Dmytro Morderer · Mayo Clinic
2025 · research · AARF
Describing Monitoring for ARIA Symptoms: Providers, Patients, and Families
Cristina De Rosa · University of Pittsburgh
2025 · research · AARG
Lysosomal De-Acidification: A prognostic & therapeutic target for tauopathy
Chih Hung Lo · Syracuse University
2025 · research · ABA
Exploring ApoE function at the Mitochondria-ER-Lipid Droplet junction
Francesca Giordano · Cnrs Dr4 Idf-sud
2025 · research · AARG-D
Role and therapeutic targeting of the cerebral microvasculature in dementia
Teresa Sanchez · Weill Cornell Medicine
2025 · research · AARF
Passive smartphone behavioral phenotypes for Alzheimer's disease screening
Katherine Hackett · Icahn School of Medicine at Mount Sinai
2025 · research · NIAP
Transcriptomic Signature for Chronic Stress Contribution to ADRD Risk
Valentina Garbarino · The University of Texas at San Antonio Health Science Center
2025 · research · AARG
Early Neural Dysfunctions in 3D Cerebral Organoids of Alzheimer’s Disease
Marc Aurel Busche · University College London
2025 · research · AARF
Epigenetic Rejuvenation in Aged Neurons from MCI and Alzheimer’s Patients
Ismail Ozcan · Salk Institute for Biological Studies
2025 · research · AARG
Aha1: A Promising Drug Target for Tau-Driven Neurodegeneration
Laura Blair · University of South Florida
2025 · research · HSR-ADRD
The role of insurance incentives in ADRD diagnosis and care disparities
Geoffrey Hoffman · Regent University
2025 · research · AARF-D
Mitochondrial Polyamine Metabolism in Neurodegeneration
Uche Medoh · Arc Research Institute
2025 · research · AARF-D
Probing the role of microglia lysosome dysfunction in AD pathogenesis
Swati Mishra · University of Washington
2025 · research · TC
Exploring how Tau Interactions Promote Co-Pathology in Primary Tauopathies
Eleanor Drummond · The University of Sydney
2025 · research · AARG
Investigating Clonal Hematopoiesis in Alzheimer's disease
Cameron Mcalpine · Icahn School of Medicine at Mount Sinai
2025 · research · AARG-D
Implementation of SAA in Latin America for early diagnosis of AD
Natalia Salvadores · Universidad Mayor
2025 · research · AARF-D
Integrative Genomic-Informed Risk Assessments to Personalize AD Care
Paulina Tolosa Tort · Regent University
2025 · research · AARF-D
Selective TERT activation to treat APOE4-drived Alzheimer’s disease
Hong Seok Shim · The University of Texas MD Anderson Cancer Center
2025 · research · AARF
Dietary Amino Acids and Gut Microbiome Interplay in AD Pathology
Yiqing Wang · Massachusetts General Hospital
2025 · research · AARG
COVID-19, 7T Imaging and AD Plasma Biomarkers
Tiffany Kautz · The University of Texas at San Antonio Health Science Center
2025 · research · ABA
TRACE-APOE: TRacking Ancestral Contributions and Effects for APOE
Hieab Adams · Erasmus University Rotterdam
2025 · research · AACSF
Validation and use of novel plasma synapse biomarkers in AD, DLB, and FTD
Raquel Taddei · University College London
2025 · research · VCID-UMD
Preventing pericyte dysfunction to treat Alzheimer's disease
Brian Macvicar · University of British Columbia
2025 · research · AARF-D
Integrating xQTL and perturbation data for AD drug repositioning
Yilin Xie · Stanford Medicine
2025 · research · AARF-D
Causal mechanisms of neural circuit failure in Alzheimer's disease
Hanyan Li · Massachusetts General Hospital
2025 · research · TC
Leonard Petrucelli and Emmerson Michael Ward -- Ascertaining the role of TMEM106B variants in modulating tauopathy in progressivesupranuclear palsy
Leonard Petrucelli · Mayo Clinic
2025 · research · TC
Understanding the role of TDP-43 co-pathology in primary tauopathies
Wilfried Rossoll · Mayo Clinic
2025 · research · AACSF
Transcriptional Signatures of Layer V Neurons Vulnerable in C9orf72 Frontotemporal Dementia
Daniel Talmasov · The Trustees Of Columbia University In The City Of New York
2025 · research · AARF
International insights on dementia care: equity in rehabilitation outcomes
Miia Rahja · Flinders University
2025 · research · AARG
Assessing novel endosomal biomarkers for AD across diverse populations
Sabrina Simoes · Columbia University
2025 · research · AARF
Dendritic contributions to impaired spatial memory in Alzheimer's disease
Jason Moore · New York University
2025 · research · ABA
Reducing APOE4 Expression as a Therapeutic Strategy
Jeffery Vance · University of Miami
2025 · research · ABA
ApoE4-Specific Biomarker Cut-offs for Accelerated Alzheimer’s Progression
Nicolai Franzmeier · Lmu University Hospital Munich (lmu Klinikum)
2025 · research · HSR-ADRD
Digital Storytelling to Promote Early Dementia Diagnosis in Rural Vietnam
Hoa Nguyen · University of Massachusetts Chan Medical School
2025 · research · AARF
The Role of ER Protein Quality Control in AD Pathogenesis
Huilun Wang · University of Virginia
2025 · research · AARG-D
Study in vivo of the modulation of INPP5D on NLRP3 inflammasome activation
Claudia Rangel-Barajas · Indiana University